Atypical Antipsychotics in Improvement of Quality of Life in Bipolar Disorder
NCT00745966 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2008-10-06
Summary
The purpose of this study is to reassure the clinical study data on atypical antipsychotics effect on quality of life in Korean Bipolar patients.
Conditions
- Naturalistic
- Observational
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Joon-Woo Bahn · Astrazeneca, Korea
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-07-31
- Primary Completion
- 2008-09-30
Countries
- South Korea
Study Locations
More Related Trials
-
An Epidemiological Registry Study to Evaluate Clinical Practice Treatment in Patients With Bipolar Disorder
NCT01455961 ·Status: COMPLETED
-
Antidepressant Treatments and Cognitive Function of Bipolar Patients
NCT04564573 ·Status: UNKNOWN
-
Effect of Quetiapine on Brain Activity Patterns in Patients With Heightened Risk of Bipolar Disorder
NCT02451306 ·Status: UNKNOWN ·Phase: NA
-
Depressive Symptoms in Acute Manic Episode
NCT00690248 ·Status: COMPLETED
-
Does Bipolar Disease Program (BDP) Intervention Improve Long Term Manic and Depressive Symptoms.
NCT00007761 ·Status: COMPLETED ·Phase: PHASE3
-
Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders
NCT00845988 ·Status: COMPLETED ·Phase: PHASE4
-
Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness
NCT00545675 ·Status: COMPLETED ·Phase: PHASE4
-
Observation Study of the Clinical Management of Bipolar Disorder
NCT01770704 ·Status: COMPLETED
-
Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode
NCT01977300 ·Status: COMPLETED ·Phase: PHASE3
-
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
NCT01710709 ·Status: COMPLETED ·Phase: PHASE3
-
Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4451
NCT01196676 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolar Disorder
NCT01663974 ·Status: TERMINATED
-
Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691)
NCT00764478 ·Status: COMPLETED ·Phase: PHASE3
-
Development and Application of Precision Treatment Strategies for Common Mental Disorders
NCT06729541 ·Status: RECRUITING ·Phase: NA
-
A Study of the Relationship of Psychosocial Function With Mood Symptoms in Offspring of Parents With Bipolar Disorder
NCT03017781 ·Status: COMPLETED
-
Improving Early Recognition and Intervention in At-risk Stages of Bipolar Disorders
NCT02456545 ·Status: COMPLETED
-
Post-Authorization Safety Surveillance Study of Asenapine in Participants With Bipolar Disorder (P08307)
NCT01495741 ·Status: COMPLETED
-
An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolar Disorder
NCT00360126 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Evaluating the Efficacy of Administered Maintenance Treatments in Bipolar Disorder I and II.
NCT01202604 ·Status: COMPLETED
-
Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness
NCT00545142 ·Status: COMPLETED ·Phase: PHASE4
-
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
NCT01395992 ·Status: COMPLETED ·Phase: PHASE3
-
Brain Derived Neurotrophic Factor as a Predictor of Response to Treatment in Bipolar Depression and Mania: 16-weeks Follow-up With Quetiapine XR
NCT00879307 ·Status: UNKNOWN ·Phase: PHASE3
-
Proof Of Mechanism Study To Determine Efficacy Of PF-04455242 In Blocking Spiradoline (PF-00345768) Stimulated Prolactin Release
NCT00988949 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
NCT01567527 ·Status: COMPLETED ·Phase: PHASE3
-
A Cohort Study of Disease Prediction Model for High-risk Population With Bipolar Disorder
NCT07031661 ·Status: RECRUITING